4.6 Article

Designer benzodiazepine rat pharmacokinetics: A comparison of alprazolam, flualprazolam and flubromazolam

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Toxicology

A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues

Arianna Giorgetti et al.

Summary: Designer benzodiazepines (DBZDs) are increasingly appearing on the NPS market and carry a higher risk, especially when used in conjunction with other central nervous system depressants.

FORENSIC TOXICOLOGY (2022)

Review Clinical Neurology

Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects

Amber N. Edinoff et al.

Summary: Designer benzodiazepines, such as flubromazolam, clonazolam, deschloroetizolam, and meclonazepam, have gained popularity in recent years and have become readily available on the internet drug market. These drugs provide strong sedation effects but also come with numerous risks and side effects.

NEUROLOGY INTERNATIONAL (2022)

Article Chemistry, Analytical

Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam

Lea Wagmann et al.

Summary: This study investigated the metabolic profile of two new psychoactive substances, clobromazolam and bromazolam, and identified metabolites in vitro and in vivo, as well as the enzymes involved in their metabolic transformations. The plasma concentrations of bromazolam in low micrograms per liter range emphasized the need for sensitive analytical methods and suitable urine screening procedures.

JOURNAL OF ANALYTICAL TOXICOLOGY (2021)

Review Neurosciences

'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports

Laura Orsolini et al.

CURRENT NEUROPHARMACOLOGY (2020)

Article Clinical Neurology

Designer benzodiazepines' pharmacological effects and potencies: How to find the information

Souleiman El Balkhi et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2020)

Review Pharmacology & Pharmacy

New psychoactive substances: a review and updates

Abu Shafi et al.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)

Editorial Material Pharmacology & Pharmacy

Designer Benzodiazepines: A Review of Published Data and Public Health Significance

H. Karl Greenblatt et al.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)

Review Substance Abuse

A Review of Alprazolam Use, Misuse, and Withdrawal

Nassima Ait-Daoud et al.

JOURNAL OF ADDICTION MEDICINE (2018)

Correction Biochemical Research Methods

The emergence of new psychoactive substance (NPS) benzodiazepines: A review (vol 10, pg 37, 2017)

Kieran R. Manchester et al.

DRUG TESTING AND ANALYSIS (2018)

Review Pharmacology & Pharmacy

Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery

Tobias Atkin et al.

PHARMACOLOGICAL REVIEWS (2018)

Article Chemistry, Medicinal

Strategy for Extending Half-life in Drug Design and Its Significance

Hakan Gunaydin et al.

ACS MEDICINAL CHEMISTRY LETTERS (2018)

Article Biochemical Research Methods

Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine

Laura M. Huppertz et al.

DRUG TESTING AND ANALYSIS (2018)

Article Biochemical Research Methods

In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples

Carolina Noble et al.

DRUG TESTING AND ANALYSIS (2017)

Editorial Material Chemistry, Medicinal

The many roles for fluorine in medicinal chemistry

William K. Hagmann

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Review Multidisciplinary Sciences

Fluorine in pharmaceuticals:: Looking beyond intuition

Klaus Mueller et al.

SCIENCE (2007)

Article Biochemistry & Molecular Biology

The role of fluorine in medicinal chemistry

Poonam Shah et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2007)

Review Biochemistry & Molecular Biology

Fluorine in medicinal chemistry

HJ Böhm et al.

CHEMBIOCHEM (2004)